CLIMATE CHANGE AND NEOLOGISMS: TOWARDS A LEXICO-SEMANTIC STUDY
BAU Journal - Society, Culture and Human Behavior · 10.10.2024 · 5 (2)
DOI: 10.54729/2789-8296.1175 ↗Kurz gefasst
Fachartikel in der Zeitschrift BAU Journal - Society, Culture and Human Behavior, online erschienen am 10.10.2024. Verfasst von Abdelfetah Nacer Idrissi.
Abstract (Originalsprache)
Climate change, a global phenomenon resulting from human activity and natural factors, is one of the most pressing concerns of our time. The impacts of global warming, rising sea levels, extreme weather events and biodiversity loss are increasingly evident. Equally remarkable is the impact this colossal challenge is having on our language, a living mirror of our collective understanding of the world. Indeed, the appearance of terms such as "ecoanxiety", "climavore" and "energy transition" are all signs of a profound transformation of the lexicon, demonstrating our growing commitment to sustainability and environmental awareness. This study, which aims to be a lexico-semantic study, aims to explore this linguistic change, by examining the formation of neologisms, the semantic evolutions of existing terms and the emotional nuances associated with the language of climate change. The aim is to better understand how society interacts with the climate crisis, how it expresses its concerns and how it considers innovative solutions.
Zitieren
APA
Idrissi, A. N. (2024). CLIMATE CHANGE AND NEOLOGISMS: TOWARDS A LEXICO-SEMANTIC STUDY. BAU Journal - Society, Culture and Human Behavior, 5(2). https://doi.org/10.54729/2789-8296.1175
Vancouver
Idrissi AN. CLIMATE CHANGE AND NEOLOGISMS: TOWARDS A LEXICO-SEMANTIC STUDY. BAU Journal - Society, Culture and Human Behavior. 2024;5(2). doi:10.54729/2789-8296.1175
BibTeX
@article{Idrissi2024,
author = {Idrissi, Abdelfetah Nacer},
title = {CLIMATE CHANGE AND NEOLOGISMS: TOWARDS A LEXICO-SEMANTIC STUDY},
journal = {BAU Journal - Society, Culture and Human Behavior},
year = {2024},
volume = {5},
number = {2},
doi = {10.54729/2789-8296.1175}
}
EUVIMED